Scientists from UC San Diego, UC Santa Barbara, and MIT developed metal nanoparticles, that can, because of their shape and polymer coating, evade the body’s immune system, allowing for free movement around the body. Additionally, a coating of a special peptide F3 molecule allows the nanoparticle to hone in on tumor cells. Perhaps this is the complimentary technology that is required to make the Kanzius Machine effective against tumors?
The scientists constructed their nanoworms from spherical iron oxide nanoparticles that join together, like segments of an earthworm, to produce tiny gummy worm-like structures about 30 nanometers long—or about 3 million times smaller than an earthworm. Their iron-oxide composition allows the nanoworms to show up brightly in diagnostic devices, specifically the MRI, or magnetic resonance imaging, machines that are used to find tumors.
“The iron oxide used in the nanoworms has a property of superparamagnetism, which makes them show up very brightly in MRI,” said Sailor [Michael Sailor, a professor of chemistry and biochemistry at UC San Diego who headed the research team --ed.]. “The magnetism of the individual iron oxide segments, typically eight per nanoworm, combine to provide a much larger signal than can be observed if the segments are separated. This translates to a better ability to see smaller tumors, hopefully enabling physicians to make their diagnosis of cancer at earlier stages of development.”
In addition to the polymer coating, which is derived from the biopolymer dextran, the scientists coated their nanoworms with a tumor-specific targeting molecule, a peptide called F3, developed in the laboratory of Erkki Ruoslahti, a cell biologist and professor at the Burnham Institute for Medical Research at UC Santa Barbara. This peptide allows the nanoworms to target and home in on tumors.
“Because of its elongated shape, the nanoworm can carry many F3 molecules that can simultaneously bind to the tumor surface,” said Sailor. “And this cooperative effect significantly improves the ability of the nanoworm to attach to a tumor.”
The scientists were able to verify in their experiments that their nanoworms homed in on tumor sites by injecting them into the bloodstream of mice with tumors and following the aggregation of the nanoworms on the tumors. They found that the nanoworms, unlike the spherical nanoparticles of similar size that were shuttled out of the blood by the immune system, remained in the bloodstream for hours.
“This is an important property because the longer these nanoworms can stay in the bloodstream, the more chances they have to hit their targets, the tumors,” said Ji-Ho Park, a UC San Diego graduate student in materials science and engineering working in Sailor’s laboratory.
Press release: UC San Diego Researchers Target Tumors with Tiny ‘Nanoworms’ …
MIT Technology Review is reporting that researchers at Harvard are using paper as the building block material for creating small microfluidic devices, potentially allowing to make cheap disposable diagnostic tests.
Neuroscientists at Johns Hopkins are working on identifying molecular mechanisms behind the sensation of heat in food and spiciness. Their latest research was published in the latest Cell.
A team from Monash University in Australia has developed a way to identify, and do a DNA analysis of embryos, which should improve the success of IVF procedures in the future.
Medtronic received FDA approval for the company’s wireless implantable defibrillators, the first devices in a product line that also includes pacemakers and resynchronization therapy pacemakers.
SEPET™ Liver Assist Device, a blood purification technology designed by Arbios Systems, Inc., a Pasadena, CA company, has been given FDA’s Investigational Device Exemption (IDE) status. The clearance paves the way for the company to begin a pivotal clinical trial. The device, a filter with special qualities, is designed for use with a standard blood dialysis system. We first reported about SEPET™ Liver Assist Device back in 
At the National Space Biomedical Research Institute, scientists are studying the human physiologic response to prolonged exposure to lunar dust, the particles of which might pose a threat to human lungs:
